OOIR: Observatory of International Research

Papers

(The H4-Index of Addiction is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)	199
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data	177
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis	132
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study	121
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries	109
Drug checking services for people who use drugs: a systematic review	105
A meta‐analysis of problem gambling risk factors in the general adult population	93
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis	86
Heroin use cannot be measured adequately with a general population survey	73
Causal mechanisms proposed for the alcohol harm paradox—a systematic review	64
Emotion regulation in substance use disorders: a systematic review and meta‐analysis	64
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021	62
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England	57
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	55
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study	53
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	50
The associations between prenatal cannabis use disorder and neonatal outcomes	48
Tobacco Use and Oral Health	48
The science of recovery capital: where do we go from here?	47
Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies	47
Outcomes associated with the use of medications for opioid use disorder during pregnancy	47
Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis	47
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it	46
The association between recreational cannabis legalization, commercialization and cannabis‐attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis	46
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression	44

Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses	43
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA	43
Cannabis use and co‐use in tobacco smokers and non‐smokers: prevalence and associations with mental health in a cross‐sectional, nationally representative sample of adults in Great Britain, 2020	43
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis	42
Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2‐year longitudinal study	41
The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta‐analysis	41
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use	41
Clinical management of cannabis withdrawal	40
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP	40
Clarifying gambling subtypes: the revised pathways model of problem gambling	40
Global prevalence of help‐seeking for problem gambling: A systematic review and meta‐analysis	40
Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019	39
For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users	39
Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non‐drinking?	39